Article Tools

Search for Related Articles

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

December 1998

Volume 178, Number 6
The Journal of Infectious Diseases 1998;178:1761–1766
0022-1899/98/7806-0029$02.00
DOI: 10.1086/314521

Serial Isolates of Cryptococcus neoformans from Patients with AIDS Differ in Virulence for Mice

Bettina C. Fries and

Arturo Casadevall

Department of Medicine and Division of Infectious Disease, Montefiore Medical Center, and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York

Serial isolates of Cryptococcus neoformans from patients with chronic infection can exhibit minor karyotype changes as a result of chromosome length polymorphism (CLP). This study investigated whether serial C. neoformans isolates with CLP from 4 patients with AIDS exhibited biologic and phenotypic differences. CLP permits the identification of serial isolates in murine mixed infection. The parameters studied were virulence in mice, capsule size, colony morphology, melanization, protease production, MICs of antifungal drugs, and growth rates in vitro. Two parameters of virulence in mice were studied: persistence in tissue and survival time after lethal infection. Serial C. neoformans isolates were shown to differ in ability to persist in vivo, virulence in a murine infection model, in vitro growth rates at 37°C, and capsule size. Melanin and protease production and MICs of antifungal drugs were comparable for serial isolates. These observations suggest microevolution of C. neoformans during human infection. This process may allow the fungal population to change, escape eradication by the immune system, and thus cause chronic infections.

Received 1 May 1998; revised 24 July 1998.

Reprints or correspondence: Dr. A. Casadevall, Dept. of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, New York 10461 ().

Cited by

Maria Carmela Esposto, Massimo Cogliati, Anna Maria Tortorano, Maria Anna Viviani. (2009) Electrophoretic karyotyping of Cryptococcus neoformans AD-hybrid strains. Mycoses 52:1, 16-23
Online publication date: 1-Feb-2009.
CrossRef
Neena Jain, Bettina C. Fries. (2008) Phenotypic Switching of Cryptococcus neoformans and Cryptococcus gattii. Mycopathologia 166:4, 181-188
Online publication date: 1-Nov-2008.
CrossRef
Ana Marisa Fusco Almeida, Marcelo Teruyuki Matsumoto, Lilian Cristiane Baeza, Rosana Bellan de Oliveira e Silva, Aline Aparecida Pizzirani Kleiner, Márcia de Souza Carvalho Melhem, Maria José Soares Mendes Giannini, . (2007) Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from Sao Paulo State, Brazil. FEMS Yeast Research 7:1,
Online publication date: 1-Feb-2007.
CrossRef
E. K. Kluger, H. K. Karaoglu, M. B. Krockenberger, P. K. Della Torre, W. Meyer, R. Malik. (2006) Recrudescent cryptococcosis, caused by Cryptococcus gattii (molecular type VGII), over a 13-year period in a Birman cat. Medical Mycology 44:6, 561-566
Online publication date: 1-Oct-2006.
CrossRef
Neena Jain, Abraham Guerrero, Bettina C. Fries. (2006) Phenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans. FEMS Yeast Research 6:4, 480-488
Online publication date: 1-Jul-2006.
CrossRef
Donatella Pietrella, Bettina Fries, Patrizia Lupo, Francesco Bistoni, Arturo Casadevall, Anna Vecchiarelli. (2003) Phenotypic switching of Cryptococcus neoformans can influence the outcome of the human immune response. Cellular Microbiology 5:8, 513-522
Online publication date: 1-Sep-2003.
CrossRef
Cletus A. D’Souza, Joseph Heitman. (2002) It infects me, it infects me not: phenotypic switching in the fungal pathogen Cryptococcus neoformans. Journal of Clinical Investigation 108:11, 1577-1578
Online publication date: 1-Jan-2002.
CrossRef
Bettina C. Fries, Carlos P. Taborda, Evan Serfass, Arturo Casadevall. (2002) Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. Journal of Clinical Investigation 108:11, 1639-1648
Online publication date: 1-Jan-2002.
CrossRef
EDNA S. KANESHIRO, DONGGEUN SUL, MIREILLE BASSELIN, OLIVER KAYSER. (2001) Pneumocystis carinii Synthesizes Four Ubiquinone Homplogs: Inhibition by Atovaquone and Bupravaquone but not by Stigmatellin. The Journal of Eukaryotic Microbiology 48:s1, 172s-173s
Online publication date: 1-Jul-2001.
CrossRef
  • Presented in part: 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, September 1996 (abstract B049).

    Animal experiments were done according to the guidelines of the institute.

    Grant support: NIH (AI‐22774 and AI‐33142); Burroughs Wellcome Developmental Therapeutics Award; Howard Hughes postdoctoral fellowship grant (to B.C.F.).

Close Popup